Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -130.79%-9.7M | -71.27%5.2M | 52.00%22.8M | 60.88%58.4M | -130.85%-6.2M | 305.88%31.5M | -33.46%18.1M | 248.84%15M | -19.87%36.3M | -47.93%20.1M |
| Net income from continuing operations | 92.06%-12.4M | -6.35%-6.7M | 350.00%6M | -68.47%-161.9M | 121.97%2.9M | -337.25%-156.1M | 77.82%-6.3M | 87.23%-2.4M | -21.49%-96.1M | 81.09%-13.2M |
| Operating gains losses | 0.00%400K | -25.00%300K | -40.00%300K | 19.05%2.5M | 33.33%1.2M | 100.00%400K | 0.00%400K | -16.67%500K | -41.67%2.1M | -18.18%900K |
| Depreciation and amortization | -48.54%8.8M | -46.99%8.8M | -37.87%10.5M | -30.82%58.8M | -49.38%8.2M | -20.83%17.1M | -26.55%16.6M | -31.30%16.9M | -13.09%85M | -38.64%16.2M |
| Asset impairment expenditure | --0 | ---- | ---- | --211M | --0 | --211M | ---- | ---- | --0 | --0 |
| Deferred tax | 91.83%-4.7M | 0.00%-2.3M | 330.00%2.3M | -64.56%-59.9M | 115.52%900K | -319.71%-57.5M | 77.88%-2.3M | 84.62%-1M | -24.66%-36.4M | 77.43%-5.8M |
| Other non cashItems | -43.75%2.7M | 0.00%2.7M | -30.95%2.9M | 0.78%12.9M | -20.00%1.2M | -41.46%4.8M | 92.86%2.7M | -16.00%4.2M | 25.49%12.8M | -71.15%1.5M |
| Change In working capital | -135.00%-4.2M | -62.86%2.6M | 141.94%1.3M | -106.98%-4.7M | -205.64%-20.6M | 328.57%12M | -83.13%7M | -1,650.00%-3.1M | 1,782.50%67.3M | -62.36%19.5M |
| -Change in receivables | 13.76%12.4M | 900.00%3M | -240.00%-5.1M | -51.04%16.4M | 219.05%6.7M | 81.67%10.9M | -98.86%300K | -66.67%-1.5M | 393.86%33.5M | -94.20%2.1M |
| -Change in inventory | 200.00%6.3M | -134.38%-5.5M | -78.57%2.4M | -16.22%6.2M | 29.67%-14.7M | -164.95%-6.3M | -57.67%16M | 158.33%11.2M | -74.13%7.4M | -185.31%-20.9M |
| -Change in prepaid assets | -5.45%-5.8M | -106.67%-100K | -113.64%-300K | -83.44%2.6M | -18.52%4.4M | -191.67%-5.5M | 400.00%1.5M | -54.17%2.2M | 206.08%15.7M | 590.91%5.4M |
| -Change in payables and accrued expense | -232.56%-17.1M | 148.15%5.2M | 128.67%4.3M | -379.44%-29.9M | -151.67%-17M | 168.25%12.9M | 51.13%-10.8M | -196.77%-15M | 267.19%10.7M | 521.79%32.9M |
| Tax refund paid | -50.00%-300K | ---200K | -400.00%-500K | -118.75%-300K | --0 | -115.38%-200K | --0 | 87.50%-100K | 144.44%1.6M | --1M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -130.79%-9.7M | -71.27%5.2M | 52.00%22.8M | 60.88%58.4M | -130.85%-6.2M | 305.88%31.5M | -33.46%18.1M | 248.84%15M | -19.87%36.3M | -47.93%20.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 79.07%-3.6M | 45.65%-5M | 10.10%-8.9M | 29.93%-41.9M | 73.95%-5.6M | -4.24%-17.2M | 8.00%-9.2M | 16.10%-9.9M | 46.70%-59.8M | 22.66%-21.5M |
| Net PPE purchase and sale | 80.33%-3.6M | 64.58%-5.1M | 25.00%-9M | 16.03%-50.8M | 71.76%-6.1M | -10.24%-18.3M | -39.81%-14.4M | 0.00%-12M | 46.27%-60.5M | 22.86%-21.6M |
| Net business purchase and sale | --0 | --0 | --0 | --6.9M | --0 | --0 | --5M | --1.9M | --0 | --0 |
| Net other investing changes | ---- | -50.00%100K | -50.00%100K | 185.71%2M | 400.00%500K | 1,000.00%1.1M | -33.33%200K | 0.00%200K | 75.00%700K | -50.00%100K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 79.07%-3.6M | 45.65%-5M | 10.10%-8.9M | 29.93%-41.9M | 73.95%-5.6M | -4.24%-17.2M | 8.00%-9.2M | 16.10%-9.9M | 46.70%-59.8M | 22.66%-21.5M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 342.35%20.6M | 79.09%-2.3M | -25,700.00%-25.8M | -174.58%-22.3M | -112.00%-2.7M | -136.64%-8.5M | -27.91%-11M | 98.61%-100K | 260.24%29.9M | 965.38%22.5M |
| Net issuance payments of debt | 547.06%22.8M | 98.77%-100K | -710.53%-23.2M | -123.24%-9.6M | -100.78%-200K | -119.62%-5.1M | -55.77%-8.1M | 173.08%3.8M | 192.91%41.3M | 12,950.00%25.7M |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | 35.29%-2.2M | 24.14%-2.2M | 33.33%-2.6M | -11.40%-12.7M | 21.88%-2.5M | -21.43%-3.4M | 14.71%-2.9M | -95.00%-3.9M | -96.55%-11.4M | -33.33%-3.2M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 342.35%20.6M | 79.09%-2.3M | -25,700.00%-25.8M | -174.58%-22.3M | -112.00%-2.7M | -136.64%-8.5M | -27.91%-11M | 98.61%-100K | 260.24%29.9M | 965.38%22.5M |
| Net cash flow | ||||||||||
| Beginning cash position | -94.58%1.3M | -86.97%3.4M | -27.49%15.3M | 43.54%21.1M | --29.8M | 179.07%24M | --26.1M | 43.54%21.1M | -79.95%14.7M | --0 |
| Current changes in cash | 25.86%7.3M | 0.00%-2.1M | -338.00%-11.9M | -190.63%-5.8M | -168.72%-14.5M | 167.44%5.8M | -124.42%-2.1M | 134.01%5M | 110.92%6.4M | 157.32%21.1M |
| End cash Position | -71.14%8.6M | -94.58%1.3M | -86.97%3.4M | -27.49%15.3M | -27.49%15.3M | --29.8M | 179.07%24M | --26.1M | 43.54%21.1M | 43.54%21.1M |
| Free cash from | -200.76%-13.3M | -97.30%100K | 360.00%13.8M | 131.40%7.6M | -720.00%-12.3M | 141.38%13.2M | -78.11%3.7M | 138.96%3M | 64.04%-24.2M | -114.15%-1.5M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.